Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Comments on 'Anti-IgE therapy for eosinophilic disorders'
Murat Salihoglu1, Ercan Karabacak, Ali Kutlu
1Department of Otolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey drmuratsali@gmail.com Department of Dermatology, GATA Haydarpasa Training Hospital, Istanbul, Turkey Department of Allergy and Immunology, GATA Haydarpasa Training Hospital, Istanbul, Turkey Department of Pathology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
EPS and iPS Cells in Disease Research
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

